TCM
MDT icon

Tekla Capital Management’s Medtronic MDT Stock Holding History

Tekla Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-82,700
Closed -$5.54M – 149
2015
Q3 		$5.54M Buy
+82,700
New +$6.09M 0.2% 97

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Tekla Capital Management's MDT Position: Q2 2023 in Review

Tekla Capital Management reduced its Medtronic (MDT) stake by 0.03% in Q2 2023, selling an estimated $8.61K and leaving 344,417 shares worth $30.3M. The position accounts for 1.19% of the portfolio, ranked #20.

Tekla Capital Management first reported a position in MDT in Q3 2015 and has held it in 32 quarters since. The position peaked at $75.3M in Q3 2021. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

  • Tekla Capital Management held 344,417 shares of Medtronic worth $30.3M as of Q2 2023.
  • Tekla Capital Management sold 100 Medtronic shares in Q2 2023, an estimated $8.61K.
  • Medtronic made up 1.19% of Tekla Capital Management's portfolio in Q2 2023, its #20 holding.
  • Tekla Capital Management first reported a position in Medtronic in Q3 2015 and has held it in 32 quarters since.
  • Tekla Capital Management's Medtronic position peaked at $75.3M in Q3 2021.
  • 2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.